bpc 157 fda warning 2025 panel backs compounded BPC-157, KPV peptides in win for RFK Jr fda warning compounded peptides bpc-157

FDA's stated reasons: Immunogenicity risk Could trigger immune reactions Impurities Compounded versions may be contaminated Lack of characterization Don't fully understand the molecules No human safety data Haven't been properly tested Reported adverse events Some have documented side effects The DOJ Prosecution: $1.79 Million Forfeiture In a landmark case, the Department of Justice prosecuted Tailor Made Compounding LLC for distributing unapproved peptides including BPC-157

Study procedure Rats were deeply anesthetized using pentobarbital at a dose of 50mg/kg

They were all brought in through the 510 approval process

Of course, this can change depending on whether you have specific healthcare needs or require an in-home aide